These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 28917831)

  • 21. Using evidence to decision frameworks led to guidelines of better quality and more credible and transparent recommendations.
    Meneses-Echavez JF; Bidonde J; Montesinos-Guevara C; Amer YS; Loaiza-Betancur AF; Tellez Tinjaca LA; Fraile Navarro D; Poklepović Peričić T; Tokalić R; Bala MM; Storman D; Swierz M; Zając J; Flórez ID; Schünemann H; Flottorp S; Alonso-Coello P
    J Clin Epidemiol; 2023 Oct; 162():38-46. PubMed ID: 37517506
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Guidelines that use the GRADE approach often fail to provide complete economic information for recommendations: A systematic survey.
    Riva JJ; Bhatt M; Brunarski DJ; Busse JW; Martins CC; Xie F; Schünemann HJ; Brozek JL
    J Clin Epidemiol; 2021 Aug; 136():203-215. PubMed ID: 33984495
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Standardized wording to improve efficiency and clarity of GRADE EtD frameworks in health guidelines.
    Piggott T; Baldeh T; Dietl B; Wiercoch W; Nieuwlaat R; Santesso N; Coello PA; Schünemann HJ
    J Clin Epidemiol; 2022 Jun; 146():106-122. PubMed ID: 35041970
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Defining decision thresholds for judgments on health benefits and harms using the Grading of Recommendations Assessment, Development and Evaluation (GRADE) Evidence to Decision (EtD) frameworks: a protocol for a randomised methodological study (GRADE-THRESHOLD).
    Morgano GP; Mbuagbaw L; Santesso N; Xie F; Brozek JL; Siebert U; Bognanni A; Wiercioch W; Piggott T; Darzi AJ; Akl EA; Verstijnen IM; Parmelli E; Saz-Parkinson Z; Alonso-Coello P; Schünemann HJ
    BMJ Open; 2022 Mar; 12(3):e053246. PubMed ID: 35273045
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Developing Evidence to Decision Frameworks and an Interactive Evidence to Decision Tool for Making and Using Decisions and Recommendations in Health Care.
    Rosenbaum SE; Moberg J; Glenton C; Schünemann HJ; Lewin S; Akl E; Mustafa RA; Morelli A; Vogel JP; Alonso-Coello P; Rada G; Vásquez J; Parmelli E; Gülmezoglu AM; Flottorp SA; Oxman AD
    Glob Chall; 2018 Sep; 2(9):1700081. PubMed ID: 31565348
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Stakeholders apply the GRADE evidence-to-decision framework to facilitate coverage decisions.
    Dahm P; Oxman AD; Djulbegovic B; Guyatt GH; Murad MH; Amato L; Parmelli E; Davoli M; Morgan RL; Mustafa RA; Sultan S; Falck-Ytter Y; Akl EA; Schünemann HJ
    J Clin Epidemiol; 2017 Jun; 86():129-139. PubMed ID: 28377194
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The GRADE approach, Part 2: Evidence to decision frameworksoutlining decision-making in health.
    Quilodrán C; Kirmayr M; Valente B; Pérez-Bracchiglione J; Garegnani L; Franco JVA
    Medwave; 2021 May; 21(4):e8182. PubMed ID: 34086664
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Indirectness (transferability) is critical when considering existing economic evaluations for GRADE clinical practice guidelines: a systematic review.
    Riva JJ; Bhatt M; Martins CC; Brunarski DJ; Busse JW; Xie F; Schünemann HJ; Brozek JL
    J Clin Epidemiol; 2022 Aug; 148():81-92. PubMed ID: 35462047
    [TBL] [Abstract][Full Text] [Related]  

  • 29. No. 367-2019 Canadian Guideline for Physical Activity throughout Pregnancy.
    Mottola MF; Davenport MH; Ruchat SM; Davies GA; Poitras V; Gray C; Jaramillo Garcia A; Barrowman N; Adamo KB; Duggan M; Barakat R; Chilibeck P; Fleming K; Forte M; Korolnek J; Nagpal T; Slater L; Stirling D; Zehr L
    J Obstet Gynaecol Can; 2018 Nov; 40(11):1528-1537. PubMed ID: 30297272
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Risk management frameworks for human health and environmental risks.
    Jardine C; Hrudey S; Shortreed J; Craig L; Krewski D; Furgal C; McColl S
    J Toxicol Environ Health B Crit Rev; 2003; 6(6):569-720. PubMed ID: 14698953
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Moving from evidence to developing recommendations in guidelines: article 11 in Integrating and coordinating efforts in COPD guideline development. An official ATS/ERS workshop report.
    Schünemann HJ; Oxman AD; Akl EA; Brozek JL; Montori VM; Heffner J; Hill S; Woodhead M; Campos-Outcalt D; Alderson P; Woitalla T; Puhan MA; Falck-Ytter Y; Bousquet J; Guyatt G;
    Proc Am Thorac Soc; 2012 Dec; 9(5):282-92. PubMed ID: 23256172
    [TBL] [Abstract][Full Text] [Related]  

  • 32. How to develop cost-conscious guidelines.
    Eccles M; Mason J
    Health Technol Assess; 2001; 5(16):1-69. PubMed ID: 11427188
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome.
    Teede HJ; Misso ML; Costello MF; Dokras A; Laven J; Moran L; Piltonen T; Norman RJ;
    Fertil Steril; 2018 Aug; 110(3):364-379. PubMed ID: 30033227
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome.
    Teede HJ; Misso ML; Costello MF; Dokras A; Laven J; Moran L; Piltonen T; Norman RJ;
    Hum Reprod; 2018 Sep; 33(9):1602-1618. PubMed ID: 30052961
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Development of the WHO-INTEGRATE evidence-to-decision framework: an overview of systematic reviews of decision criteria for health decision-making.
    Stratil JM; Baltussen R; Scheel I; Nacken A; Rehfuess EA
    Cost Eff Resour Alloc; 2020; 18():8. PubMed ID: 32071560
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Integrative assessment of evidence in healthcare: the GRADE system].
    Schünemann H
    Z Evid Fortbild Qual Gesundhwes; 2009; 103(5):261-8. PubMed ID: 19645339
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Improving the use of research evidence in guideline development: 11. Incorporating considerations of cost-effectiveness, affordability and resource implications.
    Edejer TT
    Health Res Policy Syst; 2006 Dec; 4():23. PubMed ID: 17147813
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Use of Simulation Modeling to Inform Decision Making for Health Care Systems and Policy in Colorectal Cancer Screening: Protocol for a Systematic Review.
    Smith H; Varshoei P; Boushey R; Kuziemsky C
    JMIR Res Protoc; 2020 May; 9(5):e16103. PubMed ID: 32401223
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Decisions to Start, Strengthen, and Sustain Food Fortification Programs: An Application of the Grading of Recommendations Assessment, Development, and Evaluation (GRADE) Evidence to Decision (EtD) Framework in Nigeria.
    Friesen VM; Mbuya MNN; Wieringa FT; Nelson CN; Ojo M; Neufeld LM
    Curr Dev Nutr; 2022 Mar; 6(3):nzac010. PubMed ID: 35261958
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Procedures and methods of benefit assessments for medicines in Germany.
    Bekkering GE; Kleijnen J
    Eur J Health Econ; 2008 Nov; 9 Suppl 1():5-29. PubMed ID: 18987905
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.